Charlottetown, Prince Edward Island (September 10, 2019) — Pharmaceutical company Mallinckrodt plc today announced that it has sold Charlottetown-based BioVectra to international private equity firm H.I.G. Capital for $250 million USD.
"We are very excited to enter into this new chapter with H.I.G. Capital!" said Oliver Technow, President, BioVectra, "Under H.I.G Capital's stewardship we have a fantastic opportunity to continue building and growing our business right here in Atlantic Canada.”
